Buy now pay later changes when a purchase is paid for. It does not establish the quality of the item, the legitimacy of a medical claim or whether the purchase is appropriate in the first place. A financing option should therefore be evaluated separately from the product.

Understand the obligation before the payment schedule

Federal Reserve analysis describes buy-now-pay-later products as credit arrangements with features that consumers may misunderstand. OCC guidance also identifies risks such as overextension and secondary fees when repayments are linked to other accounts. Terms vary, so a small advertised installment is not a complete statement of cost or risk. Federal Reserve consumer context on buy now pay later 2026 OCC risks of buy now pay later lending

Review the actual total, timing, interest or fees, late-payment consequences and handling of refunds. A merchant's refund and the lender's repayment schedule may involve different processes. This article does not summarize the current terms of any named financing provider or imply that AXON accepts one.

Product verification comes first

For prescription medicine, FDA's BeSafeRx resource recommends checking the legitimacy of the pharmacy. For laboratory research, the institution's procurement and quality requirements still apply. The presence of a familiar payment logo does not satisfy either pathway. FDA BeSafeRx online pharmacy information

A product with uncertain benefit can create a certain debt. That asymmetry is worth recognizing before an appealing payment plan turns an unresolved purchase decision into a recurring obligation.

AXON has not verified an installment-payment arrangement, merchant eligibility or financing offer in this article. The educational conclusion is to assess the purpose and evidence for the purchase before considering payment terms. This is general consumer information, not individualized credit advice or a recommendation to finance research products for personal treatment.